Exercise program tested in adults with psoriatic arthritis
Tests a 12-week high-intensity aerobic and strength exercise program in adults with psoriatic arthritis.
Plain-language title generated from the registry record
Registry title: Combined High-Intensity Aerobic Training and Resistance Training in Psoriatic Arthritis
Key facts
- Where
- Gothenburg and Skövde, SwedenSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-65 with psoriatic arthritis who are on stable arthritis medicine. It tests a 12-week program of high-intensity aerobic and strength training.
- Age
- 18-65 years
- Sex
- All sexes can join.
- Disease stage
- Psoriatic arthritis, diagnosed by the CASPAR criteria.
- Earlier treatment
- Stable anti-rheumatic drug treatment for more than 3 months before joining and through the first 3 months of the study.
Main reasons for not taking part
- Cardiovascular disease or severe high blood pressure
- Type 1 diabetes, COPD or other severe lung disease
- Pregnancy or BMI of 35 kg/m² or more
- Already doing regular high-intensity exercise for more than 1 hour a week in the past 6 months
- Cannot understand and read Swedish
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07352696, who can take part
Where in Sweden
- Sahlgrenska University HospitalGothenburg, SwedenNo longer taking part
- Skaraborgs sjukvård, SkövdeSkövde, SwedenNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Vastra Gotaland Region
- Trial code
- NCT07352696
- Record updated
- 23 October 2026
- Original description
The goal of this randomised controlled trial is to evaluate the effects of a 12-week intervention comprising high-intensity interval aerobic training and strength training on cardiovascular function, metabolic health profile and inflammation in patients with Psoriatic arthritis. A secondary goal is to assess the intervention´s impact on physical fitness, pain, fatigue, and health-related quality of life, and to explore long-term maintenance of exercise following completion of the intervention. We hypothesize that 12 weeks of combined high-intensity interval aerobic training and strength training will improve cardiometabolic health, inflammation, and enhance physical fitness, fatigue, pain and quality of life in Psoriatic arthritis.Read full original descriptionShow less
Effects of Combined High-Intensity Aerobic Training and Resistance Training on Cardiovascular and Metabolic Health in Psoriatic Arthritis
The goal of this randomised controlled trial is to evaluate the effects of a 12-week intervention comprising high-intensity interval aerobic training and strength training on cardiovascular function, metabolic health profile and inflammation in patients with Psoriatic arthritis. A secondary goal is to assess the intervention´s impact on physical fitness, pain, fatigue, and health-related quality of life, and to explore long-term maintenance of exercise following completion of the intervention. We hypothesize that 12 weeks of combined high-intensity interval aerobic training and strength training will improve cardiometabolic health, inflammation, and enhance physical fitness, fatigue, pain and quality of life in Psoriatic arthritis.
Inclusion: Psoriatic arthritis disease according to the CASPAR (Classification Criteria for Psoriatic Arthritis) criteria; Age range 18-65 years; Stable medication on anti- rheumatic drugs for >3 months prior to inclusion and throughout the first 3 months of the study.
Exclusion: Ongoing or planned initiation (within 3 months) of structured weight reduction therapy, pharmacological obesity treatment, or bariatric bypass surgery; Cardiovascular disease; Severe hypertension; Diabetes type I; Chronic obstructive pulmonary disease or other severe pulmonary diseases; Severe functional impairment precluding participation in high-intensity aerobic exercise; Arthroplasty of large joints, lower extremities; Inability to perform a cardiopulmonary exercise testing (CPET); Pregnancy; BMI ≥35 kg/m²; Already participating in regular exercise at high intensity (BORG ≥15) for >1 hour/ week during the past 6 months; Inability to understand and read Swedish.